Viking says monthly VK2735 kept up to 90% of weight loss

Viking Therapeutics announced Sept. 22 topline results for its VK2735 obesity maintenance study. Monthly dosing kept up to 90% of mean weight lost in induction, per company. Patients switched after Week 19 to weekly, biweekly or monthly regimens. Full safety and dropout data still matter for costs and staying power.